Single-Use Technology

Overview

Disposable bioprocessing equipment pioneered in China by Henlius for antibody production, now used by the majority of Chinese biologics manufacturers and a critical single-source vulnerability exposed by COVID-19. Henlius was the first adopter of single-use technologies in China for antibody manufacturing, overcoming initial regulatory and industry skepticism through extensive discussions with regulatory bodies. The majority of Chinese biologics manufacturing facilities are now single-use-based, a transformation that Henlius claims a meaningful role in driving across the industry. (Segment 3 (10:00-15:00))